In summary, we have identified five novel lncRNAs (AL117190.1, COL4A2‐AS1, LINC00184, MEG3 and MIR22HG) related to prognosis of breast cancer, which could act as underlying prognosis biomarkers for breast cancer. Here, MIR22HG is linked to breast carcinoma.